Curriculum for Specialty Certificate Examination in Gastroenterology

Countdown to the Examination

Monday, 24 March 2014

Pancreatic cancer

2 comments:

  1. Which of the following genetic aberrations is not implicated in the pathogenesis of pancreatic carcinoma?

    1-Mutation of the p16 tumor suppressor gene
    2-Mutation of the TP53 tumor suppressor gene
    3-Mutation of the K-ras proto-oncogene
    4-Mutation of the Rb tumor suppressor gene
    5-Loss of function of the SMAD4 tumor suppressor gene

    Numerous molecular abnormalities have been identified in patients with pancreatic cancer. The most commonly detected mutation is the K-ras proto-oncogene. Mutations are detected in more than 90% of pancreatic ductal adenocarcinomas. Other genetic sites known to contribute to carcinogenesis include p16 SMAD4 and TP53 tumor suppressor genes. The Rb tumor suppressor gene is implicated in retinoblastoma.

    ReplyDelete
  2. I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
    liver already present. I started on antiviral medications which
    reduced the viral load initially. After a couple of years the virus
    became resistant. I started on HEPATITIS B Herbal treatment from
    ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
    treatment totally reversed the virus. I did another blood test after
    the 6 months long treatment and tested negative to the virus. Amazing
    treatment! This treatment is a breakthrough for all HBV carriers.

    ReplyDelete